(Total Views: 313)
Posted On: 07/25/2019 9:26:24 AM
Post# of 154136
https://www.otcmarkets.com/filing/html?id=135...6BpKXKAith
One week extension on TO. Looks like they got $3M so far. I suspect we will get the first injection and maybe other news this week.
This Amendment No. 2 (“ Amendment No. 2 ”) amends and supplements the Exercise Offer Statement on Schedule TO originally filed with the Securities and Exchange Commission on June 24, 2019, as amended on July 19, 2019, this “ Schedule TO ”), relating to an offer by CytoDyn Inc. (“ CytoDyn ” or the “ Company ”) to amend and exercise certain outstanding warrants upon the terms and subject to the conditions set forth in the Offer to Amend and Exercise Warrants to Purchase Common Stock, dated June 24, 2019 (the “ Offer to Amend and Exercise ”), which together with the Election to Participate and Notice of Withdrawal constitute the “ Offering Materials .”
This Amendment No. 2 extends the Expiration Date of the Offer to Amend and Exercise from July 24, 2019 at 5:00 p.m. (Eastern Time) to July 31, 2019 at 5:00 p.m. (Eastern Time) , unless further extended or terminated by the Company. Throughout the Schedule TO, the Offer to Amend and Exercise and the other Offering Materials, all references to the Expiration Date of the Offer to Amend and Exercise are hereby amended to refer instead to July 31, 2019 at 5:00 p.m. (Eastern Time).
As of 5:00 p.m. (Eastern Time) on July 24, 2019, 7,608,967 Original Warrants exercisable for an aggregate of 7,608,967 shares of common stock and, pursuant to the terms of the Offer to Amend and Exercise, 3,804,461 Additional Shares (as defined in the Offering Materials) have been tendered and not withdrawn.
One week extension on TO. Looks like they got $3M so far. I suspect we will get the first injection and maybe other news this week.
This Amendment No. 2 (“ Amendment No. 2 ”) amends and supplements the Exercise Offer Statement on Schedule TO originally filed with the Securities and Exchange Commission on June 24, 2019, as amended on July 19, 2019, this “ Schedule TO ”), relating to an offer by CytoDyn Inc. (“ CytoDyn ” or the “ Company ”) to amend and exercise certain outstanding warrants upon the terms and subject to the conditions set forth in the Offer to Amend and Exercise Warrants to Purchase Common Stock, dated June 24, 2019 (the “ Offer to Amend and Exercise ”), which together with the Election to Participate and Notice of Withdrawal constitute the “ Offering Materials .”
This Amendment No. 2 extends the Expiration Date of the Offer to Amend and Exercise from July 24, 2019 at 5:00 p.m. (Eastern Time) to July 31, 2019 at 5:00 p.m. (Eastern Time) , unless further extended or terminated by the Company. Throughout the Schedule TO, the Offer to Amend and Exercise and the other Offering Materials, all references to the Expiration Date of the Offer to Amend and Exercise are hereby amended to refer instead to July 31, 2019 at 5:00 p.m. (Eastern Time).
As of 5:00 p.m. (Eastern Time) on July 24, 2019, 7,608,967 Original Warrants exercisable for an aggregate of 7,608,967 shares of common stock and, pursuant to the terms of the Offer to Amend and Exercise, 3,804,461 Additional Shares (as defined in the Offering Materials) have been tendered and not withdrawn.
(1)
(0)
